Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2021-11-10 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
110年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for a company over specific periods (the first three quarters of year 110 and year 109 in the Taiwanese calendar, corresponding to 2021 and 2020). The tables include line items such as common stock, capital surplus, legal reserve, special reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, treasury stock, and total equity attributable to the parent company and non-controlling interests. This type of detailed financial data is characteristic of an Interim / Quarterly Report (IR), as it provides substantive financial data and analysis for a period shorter than a full fiscal year. The document length is 4381 characters, which is sufficient to contain actual financial data rather than just an announcement. There is no indication that this is a full Annual Report (10-K) or an Earnings Release (ER) which typically summarize results rather than provide detailed tables. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2021
2021-11-10 Chinese
110年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements or analysis, no mention of a fiscal period report, no regulatory certifications, or meeting materials. The content is a regulatory disclosure of financial status information but is very short and factual without substantive financial data or narrative. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories like Annual Report, Interim Report, or Capital Update.
2021-11-10 Chinese
110年10月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief summary table of monthly and cumulative net operating revenue figures for a company named 景岳, with comparisons to the previous year. It includes notes explaining accounting standards and reporting practices. The document length is only 764 characters, indicating it is a short summary rather than a full financial report. There is no indication of detailed financial statements, management discussion, or regulatory certifications. It is not an announcement of a report publication but rather a concise financial fact summary. Therefore, it fits best as a Fund Information / Factsheet (FS), which is a brief summary of key company facts and financials.
2021-11-10 Chinese
更正公告本公司110年第三季合併財務報告提報董事會
Regulatory Filings Classification · 90% confidence The document is a short announcement (910 characters) from a listed company (3164 景岳) regarding a correction announcement of the company's third quarter consolidated financial report submitted to the board. It includes summarized financial data for the period 110/01/01 to 110/09/30 (which corresponds to a quarterly or interim period). The document states the report was submitted to the board and approved by the audit committee on 110/11/08. However, the document itself is brief and primarily serves as a notification or correction announcement rather than the full interim report containing detailed financial statements and analysis. Given the short length and nature of the document, it fits best as a Regulatory Filing (RNS) rather than a full Interim/Quarterly Report (IR).
2021-11-08 Chinese
公告本公司110年第三季合併財務報告提報董事會
Earnings Release Classification · 95% confidence The document is a financial announcement from a company (3164 景岳) reporting its consolidated financial results for the third quarter of the year 110 (Taiwan calendar, equivalent to 2021). It includes cumulative revenue, gross profit, operating profit, pre-tax profit, net profit, earnings per share, total assets, liabilities, and equity as of the period ending 110/09/30. The document states it is a report submitted to the board and approved by the audit committee on 110/11/08. The length is short (898 characters), and it appears to be a formal announcement of the financial results rather than the full detailed interim report itself. It does not contain detailed financial statements or extensive analysis, but summary financial data. Therefore, it fits best as an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights only. 9M 2021
2021-11-08 Chinese
110年10月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, general manager, and financial department heads, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider shareholding disclosures rather than financial results, management changes, or other report types. There is no indication of an annual or quarterly report, audit report, or earnings release. The document is not a proxy solicitation, voting results, or a merger announcement. It is a notification of shareholdings by insiders, which aligns with the definition of Director's Dealing (DIRS) filings, which report personal share transactions by company directors and executives. The document length is sufficient and contains substantive data on insider holdings and changes. Therefore, the appropriate classification is DIRS.
2021-11-05 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.